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ABSTRACT 
 
 
 
Farrell, Mark Casey M.S., Purdue University, August 2015. Potential Roles for Elf3 in 
Fetal Alcohol Spectrum Disorder and Development. Major Professor: James A. Marrs. 
 
 
 
Fetal alcohol spectrum disorder is a disease caused by prenatal alcohol exposure. It 
is characterized by craniofacial abnormalities, growth retardation, central nervous 
system defects, learning disabilities and a variety of other minor defects. Even 
though it affects 2-5% of individuals born every year, very little is known about the 
mechanisms that cause it. The zebrafish (Danio rerio) presents as an interesting and 
efficient model for studying this disease. This study provides some insight into the 
mechanisms underlying observed FASD phenotypes and, more specifically, the 
transcription factor elf3, which is downregulated in response to ethanol exposure 
during early embryonic development.  Here we show a number of elf3 target genes 
that are downregulated during early development in response to ethanol exposure. 
We also give some insight into the expression pattern of elf3 in relation to zygotic 
genome activation. Translation blocking morpholino oligonucleotides were used to 
implicate Elf3 in epiboly movements during gastrulation and zebrafish tail 
development. Taken together these results help to strengthen the zebrafish as a 
model for FASD in addition to giving greater insight into both the expression pattern 
and role of Elf3 during development.
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CHAPTER 1: INTRODUCTION 
 
 
 
Fetal Alcohol Spectrum Disorder 
Fetal Alcohol Syndrome (FAS) is a disease caused by prenatal alcohol exposure, 
resulting in a variety of birth defects including craniofacial abnormalities, growth 
retardation, central nervous system defects, and even death (Sampson, Streissguth 
et al. 1997; Sokol, Delaney-Black et al. 2003). Fetal Alcohol Spectrum Disorder 
(FASD) is characterized by these same phenotypes in addition to a number of minor 
defects and learning disabilities. It is estimated anywhere between 2-5% of 
individuals born each year suffer from FASD with that prevalence being 
considerably higher among groups of low socioeconomic status (May and Gossage 
2001; May, Gossage et al. 2009; May, Baete et al. 2014). In addition, according to a 
CDC report from 2010, 7.6% of pregnant women between the ages of 18 and 44 
admitted to at least some use of alcohol during the last 30 days of their pregnancy, 
while approximately 1.4% of women of the same age group admitted to binge 
drinking while pregnant. The average frequency and intensity of women who 
reported binge drinking was, on average, three times per month with six drinks on 
each occasion. The first step towards eliminating FASD completely should be 
education. However, even knowing that alcohol consumption could cause problems 
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for their children, many women continue to drink while pregnant. Given the 
prevalence of women drinking while pregnant in the United States and the 
frequency of individuals born with FASD, it is imperative that the mechanisms 
underlying this disease be understood to help identify effective preventative and 
therapeutic measures. 
 
The molecular mechanisms underlying FASD are poorly understood. Studying 
humans in order to gain a better understanding of this disease is problematic. Most 
studies must be retrospective, in that they are done on a single individual who has 
already been born and is displaying symptoms of FASD (which may not be apparent 
immediately after birth). In addition, ethical considerations rightly limit the ability 
to study it in humans. As a result, a robust animal model must be developed in order 
to determine the mechanisms that cause FASD. Rats and mice provide interesting 
models for study, however these animals present a variety of problems as well. The 
blood-alcohol content of the mother is hard to control and must be monitored 
constantly. Such high frequency of blood work stresses her and could potentially 
skew results. In addition, pups born who are deformed are at risk for destruction 
before they can be studied (Abel 1981; Driscoll, Streissguth et al. 1990; Bilotta, 
Barnett et al. 2004). The zebrafish, however, presents as an organism in which FASD 
can be modeled in a more practical manner. 
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Modeling FASD using Zebrafish 
Zebrafish eggs are fertilized and develop externally. In addition, ethanol can pass 
through the chorion with relative ease (Lovely, Nobles et al. 2014). As a result, 
experimental conditions can be easily and reliably manipulated when using 
zebrafish in developmental studies. The embryo is also largely transparent 
throughout development. This provides an advantage as the experiment can be 
easily monitored without any significant interference with the developing embryo 
itself. The zebrafish also develops relatively quickly and has a large clutch size, 
allowing for the study of a large number of animals in a short period of time. 
Phenotypic defects seen in humans are recapitulated in zebrafish as well. 
Microphthalmia, decreased body length, craniofacial, and cardiac abnormalities 
have all been reported in zebrafish developing in the presence of ethanol (Blader 
and Strahle 1998; Bilotta, Barnett et al. 2004; Muralidharan, Sarmah et al. 2013; 
Sarmah and Marrs 2013; Muralidharan, Sarmah et al. 2015). If the molecular 
mechanisms underlying these phenotypic defects can be elucidated in zebrafish, 
then it could shed light on the causes of FASD in humans. 
 
Identifying critical developmental stages most affected by ethanol exposure in 
zebrafish will help give insight into sensitive mechanistic events. It was shown that 
as the zebrafish embryo develops, it becomes less and less sensitive to alcohol 
(Lovely, Nobles et al. 2014). If this is true for humans as well, it is important to note 
that some women may become pregnant and are yet unaware. As a result, they 
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continue on with their normal drinking habits without fear of unknown 
consequences. The CDC reports that 53.7% of non-pregnant women surveyed had at 
least one drink during the 30 days prior to taking the survey while 12.1% reported 
binge drinking. If these drinking patterns are habitual for these women, and some 
become pregnant but do not yet know it, the alcohol they consume could affect the 
embryo during its earliest stages of development. The weak barriers against ethanol 
during the earliest stages of development means that newly fertilized embryos that 
are undergoing critical early developmental processes such as zygotic genome 
activation (ZGA) are very susceptible. This event occurs at approximately 3 hours 
post fertilization (hpf) during the mid blastula transition in zebrafish and at the 4-
cell stage in humans. Previous to this event, all mRNA found within the embryo has 
been maternally deposited. Once the zygotic genome is activated, a number of 
epigenetic modifications take place, a large number of genes are suddenly expressed, 
and the embryo begins to produce its own mRNA (Vastenhouw, Zhang et al. 2010; 
Lindeman, Andersen et al. 2011; Andersen, Reiner et al. 2012; Lee, Bonneau et al. 
2013; Potok, Nix et al. 2013). Considering there is evidence that epigenetic changes 
are, at least, partially responsible for the teratogenic effects of ethanol exposure 
during development, this important event needs to be studied in greater detail 
within the context of an FASD model (Haycock 2009). 
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Ethanol Exposure and Zygotic Genome Activation 
Recent research has provided greater insight into the influence of ethanol on ZGA. 
Our lab used a GeneChip Microarray to analyze all genes expressed at 4.5 hpf, 
comparing gene expression in embryos treated with alcohol to untreated control 
embryos. This time point was chosen to examine how the first set of genes an 
embryo transcribes are being affected by ethanol exposure. Two hundred ninety 
three genes were found to be significantly dysregulated in the ethanol treated 
embryos. Of these genes, 31 encoded transcription factors, including those critical 
for ZGA such as sox2, which is important in maintaining pluripotency as well as 
neural progenitor identity in addition to a variety of other important biological 
processes (Graham, Khudyakov et al. 2003). Find Individual Motif Occurances 
(FIMO) analysis was run on 11 of these transcription factors to estimate the number 
and location of binding sites in the zebrafish genome and, therefore, number of 
potential targets for each transcription factor. These potential targets were then 
compared with the 293 ethanol dysregulated genes to identify potential 
transcription targets for these factors. Interestingly, the consensus sequence of a 
transcription factor named E-74 like factor 3 (Elf3) was found in the largest number 
of genes dysregulated in response to ethanol at 4.5 hpf (Fig. 1a, b). Many of these 
targets were also targets of the critical ZGA factor, Sox2 (Fig. 1c). Even though Elf3 
has a large number of predicted targets, which include targets shared with Sox2, 
little is known about its functions, especially within the context of early embryonic 
development. 
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The Structure of Elf3 and other Ets transcription factors 
ELF3 (also called ESX, ERT, ESE-1, EPR-1, JEN) is a member of the E26 
transformation specific (ETS) family of transcription factors. These transcription 
factors are so named because they share a highly conserved DNA binding domain 
named the ETS domain (Fig. 2). These factors can be further divided into sub-
families based on the degree of similarity of the amino acid sequence of this domain. 
All ETS transcription factors share a consensus sequence of “GGA”, which is the core 
of a 10 BP sequence that is recognized by the ETS domain. The variable sequences 
that flank this core are what determines which ETS transcription factor(s) will be 
able bind (Wasylyk, Hahn et al. 1993). The ETS domain present in ELF3 is unique in 
amino acid sequence, and doesn’t appear to group within any known sub-family of 
ETS transcription factors. Even though the primary amino acid sequence is different, 
ELF3 has been shown to function quite similarly to the ETS domains of ETS-1 and 
ETS-2. In addition to a functionally conserved ETS domain, ELF3 contains two other 
regions required for its function. The first is the Pointed domain, which is found in 
other members of the ETS family as well. The role of this domain, however, is not 
entirely clear. There is some evidence that it plays roles in dimerization, 
transactivation and transformation in other members of the ETS family. The third 
catalytic domain present in ELF3 is the A/T Hook domain.  Transcription factors 
that contain this domain, often bind to “AT” rich regions of DNA (Oettgen, Alani et al. 
1997; Aravind and Landsman 1998; Kopp, Wilder et al. 2007). Although the Pointed 
and ETS domains are seen in other members of the ETS family, the A/T Hook 
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domain is unique, and is usually seen in the High Mobility Group (HMG) family of 
transcription factors in Drosophila (Aravind and Landsman 1998). Taken together, 
the structure of Elf3 clearly follows that of other ETS transcription factors, while 
also containing a unique A/T Hook domain, suggesting a unique function for this 
factor. 
 
The Role of Elf3 in Cancer and Inflammation 
The ETS family of transcription factors has been implicated in a variety of biological 
processes including proliferation, differentiation and survival of many different 
cellular lineages during embryonic development. These factors also control 
oncogenic transformation in adult tissues (Wasylyk, Hahn et al. 1993; Remy and 
Baltzinger 2000; Kageyama, Liu et al. 2006; Jedlicka and Gutierrez-Hartmann 2008; 
Haycock 2009). There is a growing body of research that indicates Elf3 is one of the 
Ets transcription factors that plays a role in the development of cancer. This 
research has illustrated that ELF3 is involved in the transformation of mammary 
epithelial cells in breast cancer (Chang, Scott et al. 1997; Kaplan, Wang et al. 2004; 
Prescott, Koto et al. 2004; Schedin, Eckel-Mahan et al. 2004). There is also evidence 
that ELF3 positively regulates TGF-βRII, inhibiting tumorigenesis (Chang, Lee et al. 
2000; Kim, Im et al. 2000; Lee, Chang et al. 2003). In addition to breast cancer, Elf3 
has been implicated in colorectal cancer, lung cancers, and synovial sarcomas  
(Tymms, Ng et al. 1997; Allander, Illei et al. 2002; Lee, Chang et al. 2003; Kohno, 
Okamoto et al. 2006; Lee, Bahn et al. 2008).  
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Although the role Elf3 plays in certain cancers may be important, it plays roles in 
other biological processes that also must be examined thoroughly. 
 
In addition to its role in oncogenesis, ELF3 is involved in inflammation. The 
expression of ELF3 can be driven by certain proinflammatory cytokines such as 
interleukin-1b (IL-1b) and tumor necrosis factor-α (TNF-α) via the transcription 
factor nuclear factor-κB (NF-κB) in monocytes, bronchial epithelial cells, 
chondrocytes and osteoblasts (Rudders, Gaspar et al. 2001; Grall, Gu et al. 2003; 
Brown, Gaspar et al. 2004; Wang, Fang et al. 2004; Grall, Prall et al. 2005; Peng, Tan 
et al. 2008; Wu, Duan et al. 2008; Zhan, Yuan et al. 2010; Kushwah, Oliver et al. 
2011; Oliver, Kushwah et al. 2012). This is especially interesting considering that 
under normal conditions, ELF3 expression is restricted to epithelial tissues 
(Andreoli, Jang et al. 1997; Oettgen, Alani et al. 1997; Tymms, Ng et al. 1997). 
Additionally, expression of Elf3 has been linked directly to increased expression of 
interleukin-6 (IL-6), leading to the differentiation of certain T-cells during the 
inflammatory response (Kushwah, Oliver et al. 2011; Oliver, Kushwah et al. 2012). It 
is clear that ELF3 is important in a variety of biological processes, but very little is 
known about it within the context of development, especially early development. 
 
The Role of Elf3 in Development 
Elf3 has been implicated in some developmental processes, but overall, very little is 
known about its role in early development. There is evidence that ELF3 is important 
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during the differentiation of the intestinal epithelium. Approximately 30% of mice 
with a null mutation of Elf3 (Elf3-/-) die in utero. The ones that survive exhibit a 
“wasting syndrome”. Mice that have this “wasting syndrome” characteristically look 
malnourished, have watery diarrhea and are generally lethargic. These Elf3 null 
mice also have severe morphological defects within their intestine including poor 
villus and microvillus formation. In addition, many enterocytes and mucus secreting 
goblet cells fail to fully differentiate. These enterocytes have low levels of TGF-βRII 
which is partially responsible for inducing the differentiation of epithelial cells (Ng, 
Waring et al. 2002; Oliver, Kushwah et al. 2012). Although these observations are 
relatively preliminary, Elf3 appears to play a critical role in intestinal development. 
 
ELF3 appears to be involved in mammary gland development and involution as well. 
Elevated levels of Elf3 mRNA have been detected in the mammary gland epithelium 
during pregnancy and early lactation in mice. In addition, ELF3 positively regulates 
the whey acidic protein (WAP) gene, which is a major protein found in milk and is 
important in regulating the proliferation of mammary epithelial cells. Elevated 
levels of Elf3 are also found following weaning, during involution of the mammary 
glands, suggesting it may play a role in the apoptotic pathway as mammary tissues 
are deconstructed and the epithelial cells are removed (Neve, Chang et al. 1998; 
Oliver, Kushwah et al. 2012). 
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ELF3 has also been associated with the development of the epidermal skin epithelia 
and the epithelia of the cornea. It was shown that ELF3 expression is induced during 
human keratinocyte division. It activates expression of small proline-rich protein 2A 
(SPRR2A), Transglutamase-3, and Proflaggrin, which are all associated with 
karatinocyte differentiation (Andreoli, Jang et al. 1997; Oettgen, Alani et al. 1997; 
Oliver, Kushwah et al. 2012). In addition, ELF3 is upregulated during differentiation 
of epithelial cells in the cornea of the eye. This is linked to the upregulation of K12 
keratin, which is associated with terminal differentiation of corneal epithelia 
(Yoshida, Yoshida et al. 2000; Oliver, Kushwah et al. 2012).  
 
Additionally, some research has been done on the role of Elf3 during 
preimplantation development of mouse embryos. It has been shown that expression 
of Elf3 is increased following fertilization. Additionally, siRNA techniques were used 
to knockdown Elf3 expression. Less than 60% of treated embryos survived to the 
blastocyst stage. Triple knockdown of three ETS transcription factors (Elf3, Etsrp71 
and Spic) resulted in a reduction in expression of genes that contain ETS regulation 
sites including Elf3-1a and Oct3/4 (Kageyama, Liu et al. 2006). Taken together, it is 
clear that ELF3 is important in a variety of biological processes. However, very little 
work has been done on the role it plays in early development. Even less work has 
been done on the role it plays during zebrafish development. If we are to reveal the  
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mechanisms underlying FASD phenotypes using zebrafish as a model, we must also 
gain a greater understanding of the importance Elf3 has during early embryonic 
development. 
 
Research Goals 
The goal of this research is to strengthen the zebrafish as a model for FASD and give 
some insight into the role Elf3 plays during early embryonic development. Elf3 
appears to be involved in a wide variety of biological processes including 
inflammation, differentiation of epithelia, and oncogenic transformation. However, 
there is much more evidence for its involvement in cancer progression than in 
development. This is especially true for early development. Interestingly, our 
laboratory’s microarray experiment, showed that elf3 expression was reduced in 
response to ethanol exposure during early development. Elf3 has a large number of 
potential target consensus sequences in a large number of genes, many of which are 
also targets of the important pluripotency transcription factor, Sox2. Other labs have 
shown that almost one third of elf3-/- mice die in utero, further implicating its 
importance in early embryonic development (Ng, Waring et al. 2002). Taken 
together, it is clear that a greater understanding of the role elf3 plays during early  
development and its response to ethanol exposure will both strengthen the 
zebrafish as a model for studying FASD and give greater insight into the importance 
of this transcription factor.  
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Our hypothesis was that downregulation of elf3 is partially responsible for observed 
FASD phenotypes in zebrafish and its knockdown will result in similar defects. In 
order to test this hypothesis, we used Quantitative Polymerase Chain Reaction 
(qPCR) to measure the dysregulation of Elf3 target genes in response to ethanol 
exposure at 4.5 hpf. We also used PCR techniques to establish an expression pattern 
of elf3 with respect to ZGA. Finally, we examined which developmental processes 
Elf3 might play a role in by knocking its expression down using a translation 
blocking morpholino oligonucleotide and testing for phenotypic defects at various 
stages of early development.
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CHAPTER 2: MATERIALS AND METHODS 
 
 
 
Polymerase Chain Reaction 
Embryos were treated with 100 mM ethanol beginning at 2 hpf. Total RNA was 
extracted from ∼30 embryos per group using TRIzol (Sigma). 1 μg of RNA was used 
to synthesize cDNA using M-MLV Reverse Transcriptase (Promega, Madison, WI). 
PCR reactions were performed using Taq DNA Polymerase (Roche Diagnostics, 
Manheim, Germany), 1 μl of cDNA and 0.8 μl of elf3 specific primer. Primer seqences 
- elf3 situ F1: 5’ TCTCAACAACGCCAATCCACC 3’, elf3 situ R1: 
5’CCCTATAGTGAGTCGTATTACGGCGTCGAATCTGCTCTCC 3’. A 1.2% agarose gel was 
cast using ethidium bromide as an intercalating dye and the PCR products were ran 
through this gel. The gel was visualized using the ChemiDoc XRS+ System (Bio Rad, 
Hercules, CA). 
 
Quantitative PCR Analysis 
Quantitative PCR analysis was performed as described in Sarmah and Marrs, 2013. 
Embryos were treated with 100 mM ethanol beginning at 2 hpf. They were raised to 
4.5 hpf and total RNA was extracted from ∼30 embryos (per group) using TRIzol 
(Sigma). One μg of RNA was used to synthesize cDNA using M-MLV Reverse 
Transcriptase (Promega, Madison, WI). 1-2 μl of this cDNA (1:5 dilution) and 1 μl of 
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each primer were used in each qPCR reaction using Power SYBR Green PCR mix as a 
detector (Applied Biosystems, Foster City, CA). Two independent experiments were 
performed (one in duplicate, one in triplicate) and results were confirmed using 
findings from a previously performed microarray analysis. Thermal cycling was 
performed by a Lightcycler 480 (Roche). Primer sequences – her5 F: 5’ 
TGTAATGCTCTGTGACCCC 3’, her5 F: 5’ AGCTGGTCTTTTCAGTCTTG 3’, zgc123068 F: 
5’ GCTGGAATCTCAATGGCAGG 3’, zgc123068 R: 5’ TCTCCAGTCACCCAGTACA 3’, 
slc16a9b F: 5’ GACCCCGTCAAAAAAACCC 3’, slc16a9b R: 5’ 
CCAGCGTCACGTAATTGAG 3’, krt23 F: 5’ GGAGAAACTCAAACGACCG 3’, krt23 R: 5’ 
CTCCACTGTTTTGCTCACG 3’, rarab F3: 5’ CCAGTGATTCAGCGACTACAA 3’, rarab R3: 
5’CCGGGAAGACACAGTAAAGAG 3’, rnft1 F: 5’ CCTCTCACACATCTCCACTG 3’, rnft1 R: 
5’ GTH=GAATGCACTCATCCCTC 3’, foxm1 F: 5’; GTGGTGATCCCGAAATCAG 3’, foxm1 
R: GATGAACTTGTTTCGCCCC 3’,  
 
Morpholino Oligonucleotide and mRNA Injection 
Translation blocking morpholinos (MO) were designed by and purchased from Gene 
Tools LLC. The elf3 morpholino (5’ TTAGACTAAGTTCGCTTGACGCCAT 3’) was 
designed to target bases 0-25 in relation to the start codon of zebrafish elf3 mRNA. 
The standard control morpholino was designed against a splice-generating mutant 
at position 705 of human beta globin pre-mRNA. It has been shown that this 
morpholino has no significant biological activity in zebrafish (Gene Tools, Plymouth 
OR). A BLAST search was used to ensure there were no significant similarities found 
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between the elf3 MO binding sequence and other zebrafish mRNA sequences. A 
significant similarity was defined as a twenty-five BP long sequence having twenty 
one or more bases in common with the elf3 MO binding sequence. Approximately 4 
nl of 0.98 μg/μl (.1mM) of morpholino dissolved in RNase free water was injected 
into the yolk of embryos between the one and eight cell stages (approximately 4 ng 
per embryo). 
 
mMessage mMachine (Ambion, Austin, TX) was used to transcribe mRNA from elf3 
cDNA cloned into the pExpress-1 vector (Dharmacon GE Healthcare Bio-Sciences, 
Pittsburgh, PA). Approximately 4 nl of 50 ng/μl mRNA dissolved in RNase free water 
was coinjected with the elf3 MO into one cell embryos. In total, approximately 200 
picograms of mRNA was injected into each embryo. 
 
Epiboly Measurements and Statistical Analysis 
Epiboly measurements were performed using ImageJ Software (NIH). A line was 
drawn horizontally across the front of migrating cells. A line was drawn 
perpendicular to the horizontal beginning at the horizontal and terminating at the 
animal pole. The length of this line was measured and then the diameter of the 
embryo from animal pole to vegetal pole was measured. Percent epiboly was then 
calculated using these two measurements. Statistical analysis was performed on 
percent epiboly using unpaired, two-tailed, Student’s t-test (GraphPad Software, La 
Jolla, CA USA).
  
 
  
16 
CHAPTER 3: RESULTS 
 
 
 
Potential Elf3 Targets are Dysregulated in Response to Ethanol Exposure at 4.5 hpf 
In order to validate our Microarray results, qPCR was performed on a number of 
potential Elf3 targets that were dysregulated in response to ethanol treatment at 4.5 
hpf. Embryos were treated with ethanol at a concentration of 100mM beginning at 2 
hpf. Whole RNA was harvested from both control and ethanol treated embryos at 
4.5 hpf and was then used to synthesize cDNA. qPCR was then used to examine 
differences in levels of gene expression between control and ethanol treated 
embryos of 7 putative Elf3 targets. Each gene was tested in duplicate before being 
tested in triplicate to further confirm results. Forkhead box m1 (foxm1), hairy-
related 5 (her5), retinoic acid receptor, alpha b (rarab), solute carrier family 16, 
member 9b (slc16a9b), and ring finger transmembrane protein 1 (rnft1) were all 
found to be significantly upregulated following ethanol exposure. Keratin 23 (krt23), 
and sex-hormone binding globulin (zgc123063) were both found to be 
downregulated in ethanol treated embryos (Figure 3). These changes in gene 
expression were consistent when tested in duplicate and triplicate via qPCR and 
further confirmed the results found in the GeneChip Microarray. 
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elf3 mRNA is Not Maternally Deposited 
In order to gain a greater insight into the expression patterns of elf3 within the early 
embryo, we examined if it was maternally deposited. Whole RNA was extracted 
from embryos before (1.5 hpf) and after (4.5 hpf) ZGA. Next, cDNA was synthesized 
from this RNA and PCR was then used to amplify elf3 in either or both of the 
samples. Gel electrophoresis was then performed to visualize the results. elf3 was 
present at 4.5 hpf, as expected. Interestingly, it was not present at 1.5 hpf (Figure 4). 
Both samples were then tested in the same manner for the presence of sox2, which 
is a transcript that should be present at both of these time points. Indeed, sox2 was 
detected at both 1.5 and 4.5 hpf, confirming that the cDNA that was used was viable, 
further indicating that elf3 is likely expressed at 4.5 hpf but not at 1.5 hpf. 
 
elf3 Morpholino Injection Results in Epiboly Delay 
In order to test the involvement of elf3 in the overall development of the zebrafish 
embryo, we injected a translation blocking morpholino that specifically recognizes 
and binds to elf3 transcript into the early embryo. This elf3 morpholino was injected 
into a group of embryos between the one and eight cell stage (elf3 MO). An 
established, standard control morpholino to a human beta-globin intron mutation 
was injected into a comparable number of embryos between the one and eight cell 
stages to serve as a negative control (injected control). A third group of embryos 
were not injected with any morpholino (uninjected control). Embryos were 
collected at approximately 8.3 hpf and percent epiboly was measured. The elf3 MO 
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group of embryos showed a significant delay in epiboly (n=68, 75.9% ± 6.48% 
standard deviation) compared to both the injected (n=54, 85.7% ± 4.19% standard 
deviation) and uninjected (n=41, 81.5% ± 4.39% standard deviation) control groups 
(Fig. 5). In order to examine whether this defect was due exclusively to the 
downregulation of elf3 or due to non-specific binding of the morpholino, rat elf3 
message, to which the morpholino should not bind, was coinjected with elf3 
morpholino (elf3 MO + RNA) in an attempt to rescue the epiboly delay. Percent 
epiboly (n=57, 75.66% ± 5.44% standard deviation) in this group of embryos was 
significantly less (p < .0001) than that of the embryos in both control groups and 
was nearly identical to that of the elf3 MO group (Fig. 5). 
 
elf3 Morpholino Injection Results in a Defect in Tail Formation 
After we established that injection of the elf3 MO results in an epiboly delay, we 
wished to examine if it had any effects on the later stages of development as well. In 
order to gain a greater insight into this, we injected embryos in a similar manner, 
again creating an elf3 MO group in addition to injected and uninjected control 
groups. We found that a small number of embryos in the elf3 MO group showed a 
severe “curled tail” deformity (Figure 6). There were so few embryos that showed 
this defect, we felt it imperative that we repeat the experiment multiple times to 
ensure that this was indeed a positive result, and not just an artifact. Repeatedly, we 
saw the same defect in a small number of embryos injected with the elf3 morpholino 
(approximately 4-9%) but not in either of the control groups. In order to confirm 
  
 
  
19 
that non-specific binding of the morpholino was not causing this defect, rat elf3 
mRNA was again coinjected with the elf3 MO in an attempt to rescue the “curled tail” 
phenotype. As with the epiboly delay, the rat message was unable to rescue this 
defect as it was produced in a select few embryos in both elf3 MO and elf3 MO + 
mRNA groups but not in either control group. 
 
elf3 MO injections cause neither brain nor eye defects at 24 hpf 
Once we had established that a tail defect was consistently seen in embryos injected 
with the elf3 MO, we examined these defective embryos for any other visible defects. 
We examined especially the developing brain and eyes at 24 hpf. At this stage these 
two organ systems are easy to visualize with a microscope and any severe 
phenotypic defects would be obvious. When comparing the developing brain and 
eyes of the elf3 MO injected embryos to those of uninjected control embryos, 
however, there were no obvious phenotypic defects (Figure 7). 
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CHAPTER 4: DISCUSSION 
 
 
 
These studies have given a greater insight into the importance of Elf3 and the role it 
plays during development of the zebrafish within the context of FASD. The zebrafish 
presents as a promising model for FASD, but the affected molecular mechanisms 
during early development, when the embryo is most susceptible to ethanol 
exposure, have yet to be identified (Lovely, Nobles et al. 2014). elf3 expression is 
affected by ethanol treatment and yet, almost nothing is known about the role it 
plays during early development. Considering its large number of potential targets 
and the targets it shares with the important pluripotency factor Sox2, its 
involvement in developmental processes must be studied. 
 
We showed that a number of putative Elf3 targets are significantly dysregulated in 
response to ethanol exposure at 4.5 hpf. Our GeneChip Microarray found 56 genes 
that contained the Elf3 consensus sequence were dysregulated at this time point. 
When 7 of these genes were tested using qPCR, the results for all of them mirrored 
those found in the microarray (Fig 3). Some of these genes are of particular interest 
because of the biological processes in which they are involved. For example, foxm1 
is a gene that was found to be upregulated in response to ethanol exposure. 
Overexpression of this particular gene has been linked to epigenetic modifications 
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that can cause oncogenesis (Teh, Gemenetzidis et al. 2012). Another gene of interest 
that is upregulated in response to ethanol exposure is her5. This gene is important 
in the development of endodermal organs such as the liver and pancreas (Shin, 
Chung et al. 2008).  A third elf3 target gene tested was rarab. This gene has been 
implicated in the development of the heart, liver, pectoral fin and the midbrain-
hindbrain boundary (Linville, Radtke et al. 2009; Garnaas, Cutting et al. 2012; 
D'Aniello, Rydeen et al. 2013). This is an interesting result as cardiac and central 
nervous system defects as complications of ethanol exposure have previously been 
reported in the zebrafish FASD model (Sarmah and Marrs 2013). Although the 
implications of these dysregulated genes are unknown, here we show that Elf3 has a 
number of targets that are dyregulated in response to ethanol, some of which play 
important roles in development and may even play a role in the spectrum of 
phenotypes observed as a consequence of FASD. 
 
We also found that elf3 mRNA is likely not maternally deposited. By using sox2 as a 
positive control, it is clear that elf3 is expressed at 4.5 hpf, immediately following 
ZGA. However, elf3 message was not detected in the developing zebrafish embryo at 
1.5 hpf, immediately before ZGA. Although some elf3 transcriptional target genes 
were identified, these studies were largely done in adult tissues (Oliver, Kushwah et 
al. 2012). Other studies have shown that elf3 is expressed immediately following 
fertilization in mice. Although these findings seem to contradict previous results, 
ZGA in mice occurs at the one cell stage. Therefore, elf3 is not expressed previous to 
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fertilization and ZGA in mice but is expressed after. Here, we show that this is also 
true in zebrafish. Although ZGA occurs at a later time point, the expression pattern 
around ZGA appears to be similar to that observed in mice. This is an exciting 
finding as the conservation of this expression pattern across species further 
strengthens zebrafish as a model for studying embryonic development and FASD. 
 
Using translation blocking morpholinos to knockdown elf3 expression has given us 
greater insight into the developmental processes in which this transcription factor 
functions. Injection of this morpholino repeatedly produced a significant epiboly 
delay. Epiboly is a process, by which, the three cell layers (enveloping layer, deep 
cells and yolk syncytial layer) present in the zebrafish embryo 1 hour after the mid 
blastula transition spread and thin across the yolk, eventually completely 
enveloping it (Figure 8). At the beginning of epiboly, the yolk appears to bulge 
towards the animal pole in a process referred to as “doming”. Meanwhile, the deep 
blastomeres intercalate radially, moving towards the enveloping layer and yolk cell 
in the deep cell layer. Once doming is completed, the embryo has reached 50% 
epiboly and the deep cells begin involution (mesendoderm cells move under the 
ectoderm cells). Meanwhile, all three embryonic layers continue to spread over the 
yolk and towards the vegetal pole. A marginal band of actin forms in the yolk cell at 
the vegetal margin of these migrating cells. The purpose of this structure is to 
contract and assist in the closure of the blastopore (Holloway, Gomez de la Torre 
Canny et al. 2009). A few factors including Mitogen Activated Protein Kinase 
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Activated Protein Kinase 2 (mapkapk2) and E-Cadherin (cdh1) have been implicated 
in these critical movements. Mutants or knockdown of these genes result in 
significant epiboly delays. If the epiboly delay is too severe, the actin band begins to 
squeeze the embryo and it bursts the yolk cell, destroying the developing embryo 
(Babb and Marrs 2004; Holloway, Gomez de la Torre Canny et al. 2009). These 
epiboly defects are seen in the elf3 MO embryos. The actin band begins to contract 
before the embryo reaches 50% epiboly, resulting in a bulging of the yolk cell and an 
ovoid embryo shape. Additionally, epiboly is a measure of gastrulation progression. 
If epiboly is delayed, then it is likely that gastrulation is as well. Gastrulation delays 
have been shown to cause a variety of defects in both the patterning and 
development of a number of organs (Cooke 1985). Additionally, it has been shown 
that ethanol can induce a significant epiboly delay in zebrafish embryos (Sarmah, 
Muralidharan et al. 2013). We have shown here that Elf3 may play a role in epiboly 
movements during gastrulation. Therefore, it is possible that the observed epiboly 
delay in ethanol treated embryos is partially caused by the downregulation of elf3. 
However, more work must be done in order to further examine this complex 
relationship. Taken together, this work indicates that Elf3 is partially responsible for 
epiboly and gastrulation movements and may play a role in observed defects in 
these processes in a zebrafish FASD model. 
 
Injection of the elf3 MO also produces a severe tail deformity in a significant number 
of injected embryos. Although this phenotype does not appear in all of elf3 MO 
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embryos, it does happen consistently. It is also important to note that this defect 
never appears in either the uninjected or injected control groups. The relatively low 
frequency of individuals with this defective phenotype could be due, in part, to 
complementation. Indeed, it has been previously hypothesized that the high 
conservation seen within the ETS domain could allow for other ETS transcription 
factors to act redundantly in most individuals injected with the elf3 MO, producing 
the wild-type phenotype (Ng, Waring et al. 2002; Kageyama, Liu et al. 2006). This 
finding is especially interesting because elf3 was not implicated in tail development 
in any other animals, making this a novel observation. Interestingly, a similar defect 
has been seen separately in both embryos overexpressing inhibitors of Wnt 
signaling as well as Bmp7 mutants. (Leyns, Bouwmeester et al. 1997; Wang, Krinks 
et al. 1997; Schmid, Furthauer et al. 2000; Imai and Talbot 2001; Agathon, Thisse et 
al. 2003; Thorpe, Weidinger et al. 2005). It has been established that both Wnt and 
Bmp are critical in establishing the zebrafish tail organizer (Agathon, Thisse et al. 
2003). More specifically, Wnt8 seems to act through a transcription factor, Sp5l, to 
promote proper tail development (Thorpe, Weidinger et al. 2005). Interestingly, 
sp5l was one gene identified in our microarray that contains the Elf3 consensus 
sequence upstream of the transcription start site. Considering the elf3 MO injected 
embryos display a similar phenotype to embryos in which Wnt signaling is inhibited, 
and both of these factors appear to act on sp5l (an important factor for tail 
development), it is possible that Elf3 is associated with Wnt signaling during tail 
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development. Further work must be done to examine whether there is any 
functional connection between Wnt signaling and Elf3 during this process.  
 
Additionally, tail defects have been observed in the context of a zebrafish FASD 
model. It has been shown that ethanol exposure can induce a slight “kink” in the tail 
at 28 hpf; the severity of which appears to be dose-dependent (Sarmah and Marrs 
2013). Our results suggest Elf3 is important in regulating tail development. 
Therefore, it is possible that the downregulation of Elf3 in response to ethanol is 
partially responsible for this observed tail defect. Further analysis must be done, 
however, to examine whether or not this is likely. 
 
Injection of elf3 MO appeared to cause defects in both epiboly and tail development. 
However, neither of these defects were rescued by injection of rat elf3 mRNA. At 
first glance, this may mean that the defects produced by elf3 MO injections are an 
artifact, and may not be a true result of elf3 translation inhibition. It is also possible 
that the rat protein is not structurally similar to zebrafish Elf3, and the phenotypes 
observed were not necessarily due to unintended, off target effects. Although the 
DNA binding ETS domains of the rat and zebrafish Elf3 protein are highly similar 
(91.76% identity), the A/T Hook (52.17% identity) and Pointed (40% identity) 
domains are not as well conserved (fig. 8). Consequently, it is plausible that the 
amount of rat mRNA injected was unable to rescue the observed defects because the  
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transcribed protein was too dissimilar to that of the zebrafish and could not, 
therefore, participate in the necessary protein-protein and/or DNA binding 
interactions.  
 
It is also likely that we did not inject enough rat elf3 mRNA in order to rescue the 
observed defect. The amount of injected mRNA usually ranges from 50pg-1ng. We 
injected approximately 200pg of mRNA. Therefore, we injected a relatively low 
amount of what is considered acceptable with regards to amount of mRNA with the 
potential to rescue a given phenotype (Bill, Petzold et al. 2009). Additionally, we 
injected 4ng of elf3 MO. Therefore the amount of mRNA and MO injected may not 
have been balanced enough to rescue the epiboly and tail defects. Further work 
must be done injecting more mRNA and/or less morpholino in an attempt to rescue 
the observed phenotype. 
 
There is also some evidence that the MO we used could not produce off target effects 
by binding to other mRNA. The elf3 MO binding sequence is twenty-five base pairs 
long. Any mRNA that contains a sequence similar enough (at least 21/25 bases in 
common) would, theoretically, be able to bind to the morpholino. After performing a 
Reference Sequence (RefSeq) RNA BLAST search, the transcript identified as 
containing a twenty five bp sequence that is most similar to the elf3 MO binding 
sequence was isl lim homeobox  (isl1) mRNA. This sequence shared seventeen out of 
twenty five base pairs with the elf3 MO binding sequence. As this sequence does not 
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have the minimum of twenty-one bases in common with the first twenty-five bases 
of the elf3 transcript, it is unlikely to bind the morpholino. Considering this 
sequence is the most similar to the elf3 MO binding sequence out of all the zebrafish 
mRNA sequences in the database, it is unlikely that any endogenous zebrafish mRNA 
would be able to bind to the morpholino other than elf3 mRNA. Although elf3 MO 
injection produced an observable epiboly and tail formation defects, more research 
will be needed to validate that knockdown of elf3 is indeed responsible for these 
phenotypes. 
 
As the tail is not the only tissue beginning to form at the 24 hpf stage when this 
defect was seen, we thought it important to look for phenotypic defects in the other 
developing tissues at this time point. After thorough examination of the forming 
brain and eyes, we found no observable defect. Interestingly, the transcription 
factor rarab, which was identified as a potential elf3 target in our microarray and 
was found to be significantly upregulated according to qPCR, is involved in 
midbrain-hindbrain boundary formation (Linville, Radtke et al. 2009). Even 
considering this relationship, no defect was observed in the brain. The eyes were 
also examined for potential defects as they are also developing at this time point, 
but no obvious defect was observed.  
 
Taken together, these results implicate Elf3 in a variety of developmental processes. 
Multiple Elf3 target genes are dysregulated in response to ethanol, some of which 
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have been implicated in important developmental processes. Additionally, we 
established that elf3 transcript is not maternally deposited, and is likely only 
expressed following ZGA. We also showed that injection of an elf3 morpholino 
produces both epiboly and tail defects. These results are both novel and exciting. 
More work needs to be done, however, to confirm whether elf3 is involved in these 
developmental processes and how it functions. Additionally, whether or not elf3 is 
partially responsible for similar phenotypes in the zebrafish FASD model is a 
question that warrants further examination. Overall, however, this work provides 
insight into a transcription factor whose function is not well known, but is 
potentially a major player in multiple developmental processes and disease, 
specifically Fetal Alcohol Spectrum Disorder. 
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Figure 1. Elf3 shows the most interactions out of 11 transcription factors at 4.5 
hpf. (A)11 transcription factors showed significant with other genes in our ethanol 
dysregulated dataset, which is represented using hypergeometric probability (B; 
gold circles, transcription factors; blue circles, other factors). (C) Elf3 and Sox2 
share 39 targets but exclusively bind to 17 and 21 targets respectively in the ethanol 
dysregulated dataset. 
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Figure 2. Complete nucleotide sequence and predicted amino acid sequence of 
ESE-1. The nucleotide sequences of human ESE-1a and ESE-1b, with the deduced 
amino acid sequence (one-letter code) of the major open reading frame, are shown. 
Nucleotides are numbered at the right; amino acids are numbered at the left. The 
alternative (alt.) 69-bp exon of ESE-1b inserted into the central portion of ESE-1a is 
boxed by a dashed line and shaded. The Pointed domain, the ETS domain, and the 
A/T hook domain are boxed, shaded, and marked on the right. The termination 
codons in frame with the reading frame upstream and downstream are indicated by 
asterisks. The putative polyadenylation sequence, AATAAA, close to the 
polyadenylated 3’ end of the mRNA is double underlined. The ATTTA motif involved 
in mRNA turnover is underlined.  
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Fig 3. Potential Elf3 Targets are Dysregulated in Response to Ethanol Exposure 
at 4.5 hpf. Out of the 56 putative Elf3 targets that were dysregulated in response to 
ethanol exposure, 7 were tested for dysregulation by using RT-PCR. Five of these 
genes (foxm1, her5, rarab, slc16a9b, and rnft1) were found to be upregulated while 
the remaining two (krt23, and zgc123063) were found to be downregulated in 
response to ethanol exposure. 
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Fig 4. Elf3 mRNA is not maternally deposited. elf3 mRNA was detected at 4.5 hpf 
but not at 1.5 hpf while sox2 mRNA was detected at both of these time points.  
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Fig 5.  elf3 morpholino injection results in epiboly delay. Percent epiboly of each 
embryo was measured at 8.3 hpf and averaged for each group. The average percent 
epiboly was significantly less in both the elf3 MO group and elf3 MO + mRNA groups 
when compared to both the uninjected and injected control groups.  
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Fig. 6 elf3 Morpholino Injection Results in a Defect in Tail Formation A small number of embryos injected with elf3 
MO displayed tail development defects at 24 hpf. This defect was not seen in either the uninjected or injected control 
groups. This defect was not rescued by injection of rat elf3 mRNA. 
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Figure 7. Elf3 MO injections cause neither brain nor eye defects at 24 hpf. The 
eyes and brains of both uninjected and elf3 MO injected embryos were examined 
and compared. Both developing organs appeared to be developing normally in both 
groups of embryos. 
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Figure 8. Schematic of epiboly progression. Epiboly begins when the yolk 
(yellow) domes toward the animal pole (top), concomitant with radial intercalation 
of the deep cells of the blastoderm (green) to cover 30% of the embryo surface. At 
30% epiboly, the yolk syncytial nuclei (YSN, dark-green circles) are maintained 
within the yolk syncytial layer (YSL) beneath the blastoderm and are associated 
with microtubules (black lines, surface view) that are oriented toward the vegetal 
pole within the very thin cortical, yolk cytoplasmic layer (YCL, light blue in cross-
section). The enveloping layer (EVL, pink) forms a thin epithelial-like sheath on the 
surface of the deep cells and is connected to the YSL at the cell margin. The YCL 
cannot be distinguished from the yolk when viewed from the lateral surface. At 50% 
epiboly, the EVL and deep cells cover 50% of the embryo and lie more vegetally than 
the YSN, masking the YSN in the lateral surface view. An actin band (turquoise) 
forms in the YSL just vegetal to the margin at 50% epiboly and likely functions as a 
contractile mechanism to close the blastopore throughout the remainder of the 
epiboly process. By 75% epiboly, the YSN are located beneath the blastoderm, as 
well as vegetal to it (surface view). The blastopore is the exposed vegetal yolk, 
which continually decreases in circumference as epiboly progresses. 
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Figure 9. The zebrafish and rat Elf3 protein are dissimilar. ClustalW2 software 
was used to align the rat and Zebrafish elf3 proteins. The A/T Hook, Pointed and 
ETS domains were also aligned in a similar manner. “*” represent a shared amino 
acid while “:” represents two different, yet highly similar amino acids. The elf3 MO 
binding site was also aligned to ensure that the morpholino would not bind to the 
rat elf3 mRNA. 
